NewslettersMesenchymal Cell NewsLong-Term Safety of Treatment with Autologous Mesenchymal Stem Cells in Patients with Radiation-Induced Xerostomia: Primary Results of the MESRIX Phase I/II Randomized TrialBy Ishira - May 3, 20220241Researchers investigated the long-term safety of autologous adipose tissue-derived MSCs injections into the submandibular glands.[Clinical Cancer Research]Abstract